At close: 4:59 PM GMT+1
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
407,870.00
407,870.00
444,401.00
428,391.00
281,127.00
Cost of Revenue
40,275.00
40,275.00
32,901.00
44,138.00
27,783.00
Gross Profit
367,595.00
367,595.00
411,500.00
384,253.00
253,344.00
Operating Expense
198,631.00
198,631.00
180,860.00
181,488.00
136,490.00
Operating Income
168,964.00
168,964.00
230,640.00
202,765.00
116,854.00
Net Non Operating Interest Income Expense
7,892.00
7,892.00
1,364.00
-1,508.00
-830.00
Pretax Income
176,586.00
176,586.00
230,360.00
203,220.00
112,733.00
Tax Provision
40,302.00
40,302.00
51,693.00
43,751.00
24,379.00
Net Income Common Stockholders
136,284.00
136,284.00
178,667.00
159,469.00
88,354.00
Diluted NI Available to Com Stockholders
136,284.00
136,284.00
178,667.00
159,469.00
88,354.00
Basic EPS
7.83
--
10.27
9.16
5.08
Diluted EPS
7.83
--
10.27
9.16
5.08
Basic Average Shares
17,402.48
--
17,402.48
17,402.48
17,402.48
Diluted Average Shares
17,402.48
--
17,402.48
17,402.48
17,402.48
Total Operating Income as Reported
--
--
--
202,854.00
116,023.00
Total Expenses
238,906.00
238,906.00
213,761.00
225,626.00
164,273.00
Net Income from Continuing & Discontinued Operation
136,284.00
136,284.00
178,667.00
159,469.00
88,354.00
Normalized Income
136,282.46
136,282.46
178,728.30
159,398.35
89,005.50
Interest Income
8,075.00
8,075.00
2,457.00
9.00
88.00
Interest Expense
180.00
180.00
1,088.00
1,482.00
918.00
Net Interest Income
7,892.00
7,892.00
1,364.00
-1,508.00
-830.00
EBIT
176,766.00
176,766.00
231,448.00
204,702.00
113,651.00
EBITDA
193,977.00
193,977.00
251,838.00
224,829.00
133,258.00
Reconciled Cost of Revenue
40,275.00
40,275.00
32,901.00
44,138.00
27,783.00
Reconciled Depreciation
17,211.00
17,211.00
20,390.00
20,038.00
19,607.00
Net Income from Continuing Operation Net Minority Interest
136,284.00
136,284.00
178,667.00
159,469.00
88,354.00
Total Unusual Items Excluding Goodwill
2.00
2.00
-79.00
90.00
-831.00
Total Unusual Items
2.00
2.00
-79.00
90.00
-831.00
Normalized EBITDA
193,975.00
193,975.00
251,917.00
224,739.00
134,089.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
0.46
0.46
-17.70
19.35
-179.50
6/30/2021 - 12/18/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AMBU-B.CO Ambu A/S
113.05
-1.27%
GN.CO GN Store Nord A/S
130.75
-0.49%
DEMANT.CO Demant A/S
264.80
-0.15%
VIRO.CO ViroGates A/S
14.90
+16.41%
EMBLA.CO Embla Medical hf
36.30
+1.11%
XVIVO.ST Xvivo Perfusion AB (publ)
452.00
+1.57%
LAB Standard BioTools Inc.
1.5450
+3.00%
ACARIX.ST Acarix AB (publ)
0.3295
+3.13%
VITR.ST Vitrolife AB (publ)
219.00
+2.34%
REG1V.HE Revenio Group Oyj
27.10
-4.98%